<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263922</url>
  </required_header>
  <id_info>
    <org_study_id>HQH-201911</org_study_id>
    <nct_id>NCT04263922</nct_id>
  </id_info>
  <brief_title>Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis</brief_title>
  <official_title>Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis: A Multicentre Prospective, Randomized, Double-blind and Imitation, Positive-drug Parallel Controlled Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LinkDoc Technology (Beijing) Co. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The First Affiliated Hospital of Dalian Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre prospective, randomized, double-blind and imitation, positive-drug&#xD;
      parallel controlled clinical trail. The objective of this study is to evaluate the efficacy&#xD;
      and safety of Huaiqihuang Granule in patients with CKD stage 3 primary glomerulonephritis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic kidney disease is a common disease that affects health seriously. In some regions of&#xD;
      China, the morbidity of this kind of disease is as high as 10.8%. Primary glomerulopathy is&#xD;
      one of the pathogenesis of chronic kidney disease, which occupied 50%-60%. However, at&#xD;
      present, there is still a lack of effective means for the treatment of primary&#xD;
      glomerulonephritis in CKD stage 3. Huaiqihuang Granule is a kind of Chinese herbal medicine&#xD;
      compound preparation, Previous researches showed that Huaiqihuang has a comprehensive effect&#xD;
      on primary glomerulonephritis. In this study, there were about 40 first-class hospitals&#xD;
      participating in. We planned to enroll 466 participants, who will be randomly divided into&#xD;
      the Huaiqihuang Granule group (experimental group) and the Valsartan group (control group).&#xD;
      All participants will take medication for 48 weeks, and investigators will follow up&#xD;
      participates at weeks 0, 8,16, 24, 32, 40, 48.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2020</start_date>
  <completion_date type="Anticipated">March 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of change in Estimated Glomerular Filtration Rate (eGFR) compared to baseline</measure>
    <time_frame>48 weeks</time_frame>
    <description>Events based on eGFR measure compared to baseline calculated using the CKD-EPI formula.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in serum creatinine levels from baseline</measure>
    <time_frame>Start of treatment until the end of the treatment for 48 weeks</time_frame>
    <description>Serum creatinine is being assessed once every 8 weeks for a total of 6 times during the whole study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 24-hour urine protein ration from baseline.</measure>
    <time_frame>Start of treatment until the end of the treatment for 48 weeks</time_frame>
    <description>Urinary protein is being assessed once every 8 weeks for a total of 6 times during the whole study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in urine erythrocyte levels from baseline</measure>
    <time_frame>Start of treatment until the end of the treatment for 48 weeks</time_frame>
    <description>Urine erythrocyte is being assessed once every 8 weeks for a total of 6 times during the whole study</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Composite endpoint incidence</measure>
    <time_frame>Start of treatment until the end of the treatment for 48 weeks</time_frame>
    <description>The incidence of endpoint events：① eGFR decreased by 15% from baseline and was reviewed within 2 weeks, if no improvement was found or if the eGFR continued to decrease by 15% below baseline；② Serum creatinine doubles or enters maintenance of renal replacement therapy or death</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>Start of treatment until the end of the treatment for 48 weeks</time_frame>
    <description>The proportion of patients with adverse events to the total population.</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of adverse reactions</measure>
    <time_frame>Start of treatment until the end of the treatment for 48 weeks</time_frame>
    <description>The proportion of patients with adverse reactions to the total population</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">466</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>Huaiqihuang group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combine the use of Huaiqihuang granules and Valsartan capsule simulant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Valsartan Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combine the use of Valsartan capsule and Huaiqihuang granules simulant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Huaiqihuang granules</intervention_name>
    <description>Huaiqihuang granules, 2 bags at a time, 3 times a day. Valsartan capsule simulant, 80mg at a time, once a day. Oral administration.</description>
    <arm_group_label>Huaiqihuang group</arm_group_label>
    <other_name>B12000050755</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valsartan capsule</intervention_name>
    <description>Valsartan capsule, 80mg at a time, once a day. Huaiqihuang granules simulant, 2 bags at a time, 3 times a day. Oral administration.</description>
    <arm_group_label>Valsartan Group</arm_group_label>
    <other_name>H20030638</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosed as primary glomerulonephritis by renal biopsy&#xD;
&#xD;
          2. Male or female, 18≤age≤65&#xD;
&#xD;
          3. Blood pressure can be effectively controlled at or below 140/90mmHg&#xD;
&#xD;
          4. 30mL/（min.1.73m2）≤ eGFR&lt;60mL/（min.1.73m2）&#xD;
&#xD;
          5. 24-hour urine protein ration ≤ 2.0g/24h&#xD;
&#xD;
          6. The participants must be capable of understanding and comply with the protocol and&#xD;
             sign a written informed consent document&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diagnosed as secondary glomerulonephritis&#xD;
&#xD;
          2. Exposure to corticosteroids, immunosuppressors, tripterygium glycosides, ARBs or&#xD;
             ACEIs, without a two weeks washout period&#xD;
&#xD;
          3. Blood pressure &lt; 90/60 mmHg&#xD;
&#xD;
          4. Serum potassium &gt; 5.5 mmol/L&#xD;
&#xD;
          5. Serum albumin &lt; 30g/L&#xD;
&#xD;
          6. Unilateral or bilateral renal artery stenosis&#xD;
&#xD;
          7. Pregnant or lactating women, and participants (including males) who were unable or&#xD;
             unwilling to take adequate contraception during the study period&#xD;
&#xD;
          8. Having comorbidities that affect the progression of primary glomerulonephritis&#xD;
             (including but not limited to Malignant tumors, Systemic autoimmune diseases, Liver&#xD;
             cirrhosis, Diabetes, and Gout)&#xD;
&#xD;
          9. Allergic to the Huaiqihuang Granule or valsartan&#xD;
&#xD;
         10. Participating in another clinical trial&#xD;
&#xD;
         11. Investigators do not think it suitable for a participant to join this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hongli Lin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Dalian Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongli Lin, MD</last_name>
    <phone>+86-13332268576</phone>
    <email>linhongli@vip.163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dapeng Wang, MD</last_name>
    <phone>+86-18098875653</phone>
    <email>bobowdp@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yonghui Mao, MM</last_name>
      <phone>+86-13910913875</phone>
      <email>Mmdn2009@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Ban Zhao, MM</last_name>
      <phone>+86-13910425475</phone>
      <email>zbyule@139.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lanzhou University Second Hospital</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>730030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianqin Wang, MD</last_name>
      <phone>+86-13919038189</phone>
      <email>wangjianqin@medmail.com.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xiaochun Zhou, MM</last_name>
      <phone>+86-18393819911</phone>
      <email>1162377960@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangxi Medical University</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunhua Liao, MM</last_name>
      <phone>+86-13878889238</phone>
      <email>yunhualiao1989@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Ling Pan, MD</last_name>
      <phone>+86-15296544109</phone>
      <email>nnpanling008@sina.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Fourth Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jinsheng Xu, MD</last_name>
      <phone>+86-13931116368</phone>
      <email>xjs5766@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Yaling Bai, MD</last_name>
      <phone>+86-15081150811</phone>
      <email>snbyl@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Hebei North University</name>
      <address>
        <city>Zhangjiakou</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shengjun Liu, MB</last_name>
      <phone>+86-15530396533</phone>
      <email>15530396533@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Linlin Wang, MM</last_name>
      <phone>+86-15530396741</phone>
      <email>39012204@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lirong Hao, MD</last_name>
      <phone>+86-13633636467</phone>
      <email>hao_lirong@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Xingzhi Wang, MD</last_name>
      <phone>+86-13904506176</phone>
      <email>wang.xingzhi@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The 2nd Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jundong Jiao</last_name>
      <phone>+86-13845006919</phone>
      <email>jiaojundong@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henan Provincial people's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fengmin Shao, MM</last_name>
      <phone>+86-13607655698</phone>
      <email>fengminshao@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Yan Miao, MM</last_name>
      <phone>+86-13849101887</phone>
      <email>153miaoyan@sina.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiangcheng Xiao, MD</last_name>
      <phone>+86-13787312910</phone>
      <email>1376785378@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Ling Huang, MD</last_name>
      <phone>+86-15211043086</phone>
      <email>767935151@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The first affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science and Technology</name>
      <address>
        <city>Baotou</city>
        <state>Inner Mongolia</state>
        <zip>014010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caili Wang, MD</last_name>
      <phone>+86-13516723868</phone>
      <email>Wangcaili213@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Yaqin Kang, MM</last_name>
      <phone>+86-15149387642</phone>
      <email>142496525@we.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Chifeng University</name>
      <address>
        <city>Chifeng</city>
        <state>Inner Mongolia</state>
        <zip>024000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyi Zhao, MM</last_name>
      <phone>+86-13947695080</phone>
      <email>zxy5080@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Yongfeng Ci, MM</last_name>
      <phone>+86-15848997601</phone>
      <email>67999124@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Changzhou NO.2 People's Hospital</name>
      <address>
        <city>Changzhou</city>
        <state>Jiangsu</state>
        <zip>213000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tongqiang Liu, MD</last_name>
      <phone>+86-13775606952</phone>
      <email>Liuyf1106@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiaoping Li, MD</last_name>
      <phone>+86-13915090077</phone>
      <email>xiaopingandmax@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital of Chinese Medicine</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Sun, MD</last_name>
      <phone>+86-13505199810</phone>
      <email>jssunwei@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Qing Li, MD</last_name>
      <phone>+86-13770503286</phone>
      <email>13770503286@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Xuzhou Medical University</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <zip>221022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dong Sun, MD</last_name>
      <phone>+86-18052268639</phone>
      <email>sundong126@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Caixia Liu, MM</last_name>
      <phone>+86-18052268593</phone>
      <email>liucaixiax2@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First Bethune Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hang Yuan, MD</last_name>
      <phone>17604307906</phone>
      <email>hangyuan75@foxmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Dan Dong, MD</last_name>
      <phone>18243075191</phone>
      <email>sky-811@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ping Luo, MD</last_name>
      <phone>+86-13596187651</phone>
      <email>luopingjie@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Wenpeng Cui, MD</last_name>
      <phone>+86-13504316157</phone>
      <email>wenpengcui@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Anshan Central Hospital</name>
      <address>
        <city>Anshan</city>
        <state>Liaoning</state>
        <zip>114000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Ding, MB</last_name>
      <phone>+86-18641215599</phone>
      <email>Aszxdingwei@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Xin Zhou, MM</last_name>
      <phone>13898055716</phone>
      <email>zhouxin815@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Anshan Shuangshan Hospital</name>
      <address>
        <city>Anshan</city>
        <state>Liaoning</state>
        <zip>114000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cong Ma, MB</last_name>
      <phone>+86-13050031079</phone>
      <email>macong307@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Ruiting Lv, MM</last_name>
      <phone>+86-13889721956</phone>
      <email>lv_830826@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ansteel Group General Hospital</name>
      <address>
        <city>Anshan</city>
        <state>Liaoning</state>
        <zip>114000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Na Yi, MM</last_name>
      <phone>+86-15164233397</phone>
      <email>yina710918@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Li Ma, MM</last_name>
      <phone>+86-15841203662</phone>
      <email>luckylwhml@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Benxi Iron and Steel General Hospital of Liaoning Health Industry Group</name>
      <address>
        <city>Benxi</city>
        <state>Liaoning</state>
        <zip>117000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huimin Wang, MM</last_name>
      <phone>+86-13942463528</phone>
      <email>307502752@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Wei Wei, MM</last_name>
      <phone>15041492702</phone>
      <email>974859394@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongli Lin, MD</last_name>
      <phone>+86-13332268576</phone>
      <email>Linhongli@vip163.com</email>
    </contact>
    <contact_backup>
      <last_name>Dapeng Wang, MD</last_name>
      <phone>+86-18098875653</phone>
      <email>bobowdp@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dalian Ruikaier Nephropathy Hospital</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Xie, MD</last_name>
      <phone>+86-18098875657</phone>
      <email>wlciq007@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhe Kang, MM</last_name>
      <phone>+86-13591330148</phone>
      <email>kz1107@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Feng Zheng, MM</last_name>
      <phone>+86-13365917598</phone>
      <email>Fzheng63@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Jie Sheng, MD</last_name>
      <phone>+86-17709870357</phone>
      <email>shengjie009@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fuxin Mine General Hospital of Liaoning Health Industry Group</name>
      <address>
        <city>Fuxin</city>
        <state>Liaoning</state>
        <zip>123000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>The First affiliated Hospital of Jinzhou Medical University</name>
      <address>
        <city>Jinzhou</city>
        <state>Liaoning</state>
        <zip>121000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hongli Zhou, MD</last_name>
      <phone>+86-15841634201</phone>
      <email>26675204@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Shuo Chen, MD</last_name>
      <phone>+86-15241549185</phone>
      <email>22324173@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Liaoning Electric Power Central Hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xin Feng, MM</last_name>
      <phone>+86-13940006411</phone>
      <email>drfengxin05@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Dandan Sui, MM</last_name>
      <phone>14704052631</phone>
      <email>14704052631@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hua Zhou, MD</last_name>
      <phone>+86-18611694286</phone>
      <email>18611694286@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Dajun Liu, MD</last_name>
      <phone>+86-18940251022</phone>
      <email>xpx200820@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Li Yao, MD</last_name>
      <phone>+86-13904035673</phone>
      <email>liyao_cmu@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Tianhua Xu, MM</last_name>
      <phone>+86-13998368056</phone>
      <email>xthhtq@sina.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Central Hospital affiliated to Shenyang Medical College</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Sun, MM</last_name>
      <phone>+86-18002477026</phone>
      <email>sunyi@medmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hua Zheng, MM</last_name>
      <phone>+86-13504182239</phone>
      <email>24081306@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Yingkou Central Hospital</name>
      <address>
        <city>Yingkou</city>
        <state>Liaoning</state>
        <zip>115000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingchun Zhang, MM</last_name>
      <phone>+86-13050688336</phone>
      <email>ykyc26@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Li Guo, MM</last_name>
      <phone>15504176643</phone>
      <email>lilacgl@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiangdong Yang, MD</last_name>
      <phone>+86-18560083856</phone>
      <email>yxd683@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Ling Guo, MD</last_name>
      <phone>+86-18560083860</phone>
      <email>gulixiji@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Sixth People's Hospital affiliated to Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Niansong Wang, MD</last_name>
      <phone>+86-13916328720</phone>
      <email>wangniansong2012@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Guihua Jian, MM</last_name>
      <phone>+86-18930173172</phone>
      <email>gh238@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Xinhua Hospital Affiliated to Shanghai Jiaotong University School of medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gengru Jiang, MD</last_name>
      <phone>+86-13816238339</phone>
      <email>jianggeng-ru@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yingli Gu, MM</last_name>
      <phone>+86-13818695750</phone>
      <email>yingli_gu666@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Second Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030013</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lihua Wang, MD</last_name>
      <phone>+86-15234166600</phone>
      <email>Lihuawang236@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Xinyan Liu, MD</last_name>
      <phone>+86-13803403221</phone>
      <email>xinyanliu7011@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shanxi Provincial people's Hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>300012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rongshan Lin, MD</last_name>
      <phone>+86-18734195439</phone>
      <email>rongshanli13@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Gaohong Liu, MD</last_name>
      <phone>+86-13834661591</phone>
      <email>snowfox168408@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300211</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rong Li, MM</last_name>
      <phone>+86-13612058385</phone>
      <email>beilloa@sohu.com</email>
    </contact>
    <contact_backup>
      <last_name>Kai Rong, MM</last_name>
      <phone>+86-13920187109</phone>
      <email>kevin342686691@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kunming Yan'an Hospital</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <zip>650000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jinwen Wang, MB</last_name>
      <phone>13700697545</phone>
      <email>wjwyayy@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Hao Chen, MM</last_name>
      <phone>13987665650</phone>
      <email>983553959@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zhejiang Provincial people's Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiang He, MD</last_name>
      <phone>+86-13588870088</phone>
      <email>Strong_he@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Maosheng Chen, MD</last_name>
      <phone>+86-15868103636</phone>
      <email>cms213@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>February 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>June 9, 2021</last_update_submitted>
  <last_update_submitted_qc>June 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary Glomerulonephritis</keyword>
  <keyword>Huaiqihuang Granule</keyword>
  <keyword>CKD3</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Glomerulonephritis</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valsartan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

